Tablets Development Based on Clover Meadow Grass Phytosubstance Using Design of the Experiment Method and QdD Tools

Introduction. Quality, along with efficacy and safety, are the key characteristics of a drug. Therefore, it is important in frame of pharmaceutical development to lay the foundation for obtaining a quality product and achieving the desired product characteristics. One of the tools used for this is t...

Full description

Bibliographic Details
Main Authors: A. N. Golubev, Th. I. Nguen, V. V. Sorokin, I. E. Kauhova
Format: Article
Language:Russian
Published: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2020-08-01
Series:Разработка и регистрация лекарственных средств
Subjects:
Online Access:https://www.pharmjournal.ru/jour/article/view/823
_version_ 1797874974179983360
author A. N. Golubev
Th. I. Nguen
V. V. Sorokin
I. E. Kauhova
author_facet A. N. Golubev
Th. I. Nguen
V. V. Sorokin
I. E. Kauhova
author_sort A. N. Golubev
collection DOAJ
description Introduction. Quality, along with efficacy and safety, are the key characteristics of a drug. Therefore, it is important in frame of pharmaceutical development to lay the foundation for obtaining a quality product and achieving the desired product characteristics. One of the tools used for this is the «Quality by design» approach (QbD) - quality through development. The ICH Q8 «Pharmaceutical development» manual defines it as a systematic approach to development that starts with pre-defined goals and focuses on understanding the product and process, as well as managing the process based on reliable scientific data and quality risk management.Aim. The aim of the research is to develop the composition of tablets based on clover meadow grass phytosubstance using the QbD tool with application of mathematical model that links the composition of tablets (CMA) with its quality attributes (CQA).Materials and methods. The research was based on the concept of quality by design/quality through development. The main method for conducting the development process was design of experiments method/experiment planning with creating of individual design. The experiment planning was performed in the software package JMP Pro 14 (ver. 14. 3. 0), SAS Institute Inc., USA. The method of risk analysis-failure mode and effects analysis (FMEA)/analysis of the types and consequences of failures was used for risk assessment in research. As methods of analysis of the tablet mixture and the tablets were used the following the tests: disintegration of tablets, crushing strength of tablets, determination of hygroscopicity, determination of Carr's and Hausner index.Results and discussion. The composition of tablets based on the clover meadow grass phytosubstance obtained by direct pressing was developed. In order to develop the composition of tablets in accordance with the ICH Q8 guidelines, the first step was to create a quality target product profile. To ensure the properties specified in the quality target product profile, the component composition of the developed tablets was selected based on the selected production technology and key characteristics of both the tablet mixture and the finished product. The risk assessment for the product composition determined that the quantitative content of 4 excipients are considered as critical quality attributes of materials (CMA). CMAs affect the critical quality attributes (CQA) of the dosage form, which determine the effectiveness of the composition.Based on the initial data analysis, optimal content boundaries for each component were established. Potentially critical qualitative characteristics of the drug under development (CQA) were identified. A mathematical model linking critical quality parameters and tablet composition was obtained and analyzed.Conclusion. Based on a mathematical model, the optimal composition of tablet mixture and tablets obtained from it was determined. The tablets quality indicators corresponding to the selected composition were calculated, and the adequacy of the obtained model was evaluated by comparing calculated and real indicators. It is shown that the calculation error does not exceed 10 %, and the proposed optimization algorithm and the model derived from it can be successfully used to optimize the composition of tablets.
first_indexed 2024-04-10T01:39:21Z
format Article
id doaj.art-9314b326707441ffb2de0ac3be4ba814
institution Directory Open Access Journal
issn 2305-2066
2658-5049
language Russian
last_indexed 2024-04-10T01:39:21Z
publishDate 2020-08-01
publisher LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
record_format Article
series Разработка и регистрация лекарственных средств
spelling doaj.art-9314b326707441ffb2de0ac3be4ba8142023-03-13T09:14:01ZrusLLC Center of Pharmaceutical Analytics (LLC «CPHA»)Разработка и регистрация лекарственных средств2305-20662658-50492020-08-0193515810.33380/2305-2066-2020-9-3-51-58766Tablets Development Based on Clover Meadow Grass Phytosubstance Using Design of the Experiment Method and QdD ToolsA. N. Golubev0Th. I. Nguen1V. V. Sorokin2I. E. Kauhova3ФГБОУ ВО «Санкт-Петербургский государственный химико-фармацевтический университет» Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПХФУ Минздрава России)ФГБОУ ВО «Санкт-Петербургский государственный химико-фармацевтический университет» Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПХФУ Минздрава России)ФГБОУ ВО «Санкт-Петербургский государственный химико-фармацевтический университет» Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПХФУ Минздрава России)ФГБОУ ВО «Санкт-Петербургский государственный химико-фармацевтический университет» Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПХФУ Минздрава России)Introduction. Quality, along with efficacy and safety, are the key characteristics of a drug. Therefore, it is important in frame of pharmaceutical development to lay the foundation for obtaining a quality product and achieving the desired product characteristics. One of the tools used for this is the «Quality by design» approach (QbD) - quality through development. The ICH Q8 «Pharmaceutical development» manual defines it as a systematic approach to development that starts with pre-defined goals and focuses on understanding the product and process, as well as managing the process based on reliable scientific data and quality risk management.Aim. The aim of the research is to develop the composition of tablets based on clover meadow grass phytosubstance using the QbD tool with application of mathematical model that links the composition of tablets (CMA) with its quality attributes (CQA).Materials and methods. The research was based on the concept of quality by design/quality through development. The main method for conducting the development process was design of experiments method/experiment planning with creating of individual design. The experiment planning was performed in the software package JMP Pro 14 (ver. 14. 3. 0), SAS Institute Inc., USA. The method of risk analysis-failure mode and effects analysis (FMEA)/analysis of the types and consequences of failures was used for risk assessment in research. As methods of analysis of the tablet mixture and the tablets were used the following the tests: disintegration of tablets, crushing strength of tablets, determination of hygroscopicity, determination of Carr's and Hausner index.Results and discussion. The composition of tablets based on the clover meadow grass phytosubstance obtained by direct pressing was developed. In order to develop the composition of tablets in accordance with the ICH Q8 guidelines, the first step was to create a quality target product profile. To ensure the properties specified in the quality target product profile, the component composition of the developed tablets was selected based on the selected production technology and key characteristics of both the tablet mixture and the finished product. The risk assessment for the product composition determined that the quantitative content of 4 excipients are considered as critical quality attributes of materials (CMA). CMAs affect the critical quality attributes (CQA) of the dosage form, which determine the effectiveness of the composition.Based on the initial data analysis, optimal content boundaries for each component were established. Potentially critical qualitative characteristics of the drug under development (CQA) were identified. A mathematical model linking critical quality parameters and tablet composition was obtained and analyzed.Conclusion. Based on a mathematical model, the optimal composition of tablet mixture and tablets obtained from it was determined. The tablets quality indicators corresponding to the selected composition were calculated, and the adequacy of the obtained model was evaluated by comparing calculated and real indicators. It is shown that the calculation error does not exceed 10 %, and the proposed optimization algorithm and the model derived from it can be successfully used to optimize the composition of tablets.https://www.pharmjournal.ru/jour/article/view/823планирование экспериментаразработка лекарственных препаратовquality by design
spellingShingle A. N. Golubev
Th. I. Nguen
V. V. Sorokin
I. E. Kauhova
Tablets Development Based on Clover Meadow Grass Phytosubstance Using Design of the Experiment Method and QdD Tools
Разработка и регистрация лекарственных средств
планирование эксперимента
разработка лекарственных препаратов
quality by design
title Tablets Development Based on Clover Meadow Grass Phytosubstance Using Design of the Experiment Method and QdD Tools
title_full Tablets Development Based on Clover Meadow Grass Phytosubstance Using Design of the Experiment Method and QdD Tools
title_fullStr Tablets Development Based on Clover Meadow Grass Phytosubstance Using Design of the Experiment Method and QdD Tools
title_full_unstemmed Tablets Development Based on Clover Meadow Grass Phytosubstance Using Design of the Experiment Method and QdD Tools
title_short Tablets Development Based on Clover Meadow Grass Phytosubstance Using Design of the Experiment Method and QdD Tools
title_sort tablets development based on clover meadow grass phytosubstance using design of the experiment method and qdd tools
topic планирование эксперимента
разработка лекарственных препаратов
quality by design
url https://www.pharmjournal.ru/jour/article/view/823
work_keys_str_mv AT angolubev tabletsdevelopmentbasedonclovermeadowgrassphytosubstanceusingdesignoftheexperimentmethodandqddtools
AT thinguen tabletsdevelopmentbasedonclovermeadowgrassphytosubstanceusingdesignoftheexperimentmethodandqddtools
AT vvsorokin tabletsdevelopmentbasedonclovermeadowgrassphytosubstanceusingdesignoftheexperimentmethodandqddtools
AT iekauhova tabletsdevelopmentbasedonclovermeadowgrassphytosubstanceusingdesignoftheexperimentmethodandqddtools